https://www.biospace.com/epizyme-appoints-b-andrew-singer-b-as-chief-financial-officer
Epizyme Appoints Andrew Singer As Chief Financial Officer - BioSpace
chief financial officerandrew singerepizymeappointsbiospace
https://www.biospace.com/epizyme-reacquires-rights-to-cancer-drug-from-eisai-company-in-deal-worth-110-million
Epizyme Reacquires Rights to Cancer Drug From Eisai Company in Deal Worth $110 Million - BioSpace
https://www.biospace.com/epizyme-announces-pricing-of-public-offering-of-common-stock-641694
Epizyme Announces Pricing Of Public Offering Of Common Stock - BioSpace
public offeringcommon stockepizymeannouncespricing
https://www.annualreports.com/Company/epizyme-inc
Epizyme Inc - AnnualReports.com
epizymeincannualreports
https://www.fool.com/investing/2019/07/12/heres-why-epizyme-rose-1037-in-the-first-half-of-2.aspx
Here's Why Epizyme Rose 103.7% in the First Half of 2019 | The Motley Fool
Jul 12, 2019 - The company put a clinical hold from 2018 behind it and submitted its first-ever new drug application.
https://www.biospace.com/epizyme-announces-proposed-public-offering-of-common-stock-696049
Epizyme Announces Proposed Public Offering Of Common Stock - BioSpace
public offeringcommon stockepizymeannouncesproposed
https://www.fool.com/earnings/call-transcripts/2020/05/04/epizyme-inc-epzm-q1-2020-earnings-call-transcript.aspx
Epizyme Inc (EPZM) Q1 2020 Earnings Call Transcript | The Motley Fool
May 4, 2020 - EPZM earnings call for the period ending March 31, 2020.
earnings call transcriptepizymeincepzmq1
https://www.biospace.com/epizyme-to-present-at-upcoming-conferences-in-february-632820
Epizyme To Present At Upcoming Conferences In February - BioSpace
upcoming conferencesepizymepresentfebruarybiospace
https://www.medicaldaily.com/epizyme-identifies-novel-opportunity-treatment-genetically-defined-human-b-cell-lymphomas-234579
Epizyme identifies novel opportunity for treatment of genetically defined human B-cell lymphomas
Nov 15, 2010 - Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the...
https://www.fool.com/investing/2022/02/03/why-shares-of-epizyme-soared-321-this-week/
Why Shares of Epizyme Soared 32.1% This Week | The Motley Fool
Feb 3, 2022 - The small biopharmaceutical company bounced back after its shares lost half their value the week before.
https://robinhood.com/us/en/stocks/EPZMZZZ/
Epizyme, Contra: EPZMZZZ Stock Price Quote & News | Robinhood
You can watch EPZMZZZ and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying...
stock price quoteepizymecontranewsrobinhood
https://www.fool.com/earnings/call-transcripts/2021/08/09/epizyme-inc-epzm-q2-2021-earnings-call-transcript/
Epizyme, inc (EPZM) Q2 2021 Earnings Call Transcript | The Motley Fool
Aug 9, 2021 - EPZM earnings call for the period ending June 30, 2021.
earnings call transcriptepizymeincepzmq2
https://www.fiercebiotech.com/biotech/boehringer-ingelheim-and-epizyme-launch-300m-precision-oncology-program
Boehringer Ingelheim and Epizyme launch $300M precision oncology program | Fierce Biotech
Nov 15, 2018 - In a worldwide collaboration worth up to $300 million or more, Boehringer Ingelheim is expanding its precision oncology programs by tapping Epizyme for...
boehringer ingelheimprecision oncologyepizymelaunch